When we think about sex hormones, notably estrogens and androgens, we usually associate them with sex, gender and body development. Like all hormones, they are chemical messengers, substances produced in one part of the body ...
Feb 23, 2016
0
1
Androgen deprivation therapy (ADT) is a mainstay of prostate cancer treatment. ADT has shown survival benefit in some patients but it also has been associated with some adverse health effects and a possible link to neurocognitive ...
Oct 13, 2016
0
17
Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies.
Oct 12, 2017
0
2
Prostate cancer (PC) is one of the leading causes of global cancer-related deaths among men. While a standard systemic therapy called "androgen deprivation therapy" (ADT) is widely administered to reduce the level of androgen—the ...
Oct 19, 2021
0
27
A Monash University study into the causes of sexual dysfunction in young women has found social factors play just as important a role as hormone levels, and hormone therapy should not be prescribed as the only treatment.
Jul 22, 2020
0
1
(Medical Xpress)—For the past 70 years, androgen deprivation therapy (ADT) has been the standard treatment for men diagnosed with late-stage prostate cancer.
Jun 14, 2013
0
0
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have found new targets for potential intervention in breast cancer. These new targets could eventually increase effectiveness and reduce the undesirable ...
Jun 5, 2014
0
0
Many patients with prostate cancer are treated with drugs that lower or block hormones that fuel tumor growth. While the drugs are effective for a time, most patients eventually develop resistance to these therapies.
Nov 5, 2021
0
18
A new analysis of patients who have undergone treatment for prostate cancer shows a connection between androgen deprivation therapy (ADT)—a testosterone-lowering therapy and a common treatment for the disease—and dementia, ...
Mar 30, 2017
0
3
For patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen deprivation therapy (ADT), and doublet therapy ...
Apr 12, 2023
0
9
